News

Supes Discuss Dangers of Marijuana Farming
When it comes to reporting on the dangers of large marijuana farms, the Santa Cruz County Board of Supervisors beat The New York Times on a scoop.
 
Zach Friend and Bruce McPherson, the board’s two newest supes, submitted a letter at a meeting that suggested reforms on large marijuana farms—citing environmental degradation and law enforcement issues. What a buzzkill, right? But Friend says the study into new regulations isn’t just about busting up parties—ahem, we mean, taking away people’s right to medicine.
 
“This isn’t about individual use or access. This is about the fact that we’ve had significant neighborhood and rural impacts because we’ve had unmitigated and unregulated and unenforced grows,” Friend said at the June 18 meeting, where people showed up wearing sunglasses. “We’ve been silent on this issue, and you get to a tipping point very quickly where things get out of hand in a neighborhood and you’re trying to put a genie back in a bottle.”
 
Two days later, The New York Times wrote a long news story about what pot grows are doing to California landscapes and redwood forests. In Humboldt County, the main focus of the article, hilltops have been leveled, bulldozers have started landslides and dams are diverting water from salmon whose populations were already decimated by logging—leaving the North Coast residents feeling a little less high on life.
Many Humboldt growers also used dangerous rat poisons like D-Con, the no-fun dangers of which the Weekly reported last week. The poisons have killed endangered animals and California fishers—cute, weasel-like animals. Humboldt’s County supervisors have taken steps to get D-Con out of stores.
 
Needless to say, pot grows across California have politicians trying to weed through tricky issues. Here in Santa Cruz, the county already has a moratorium on new dispensaries—which expires in November. In light of confusing court decisions and unclear state and federal law, staff is at work studying what the county’s next homegrown ordinances should be.
 
During public comment, the talk of regulation at the meeting got reform-minded folks, like medical marijuana attorney/hero Ben Rice, talking about the benefits for testing crops for potency and chemicals. Friend says—bluntly—that’s out of the scope of what the county can tackle.
  • https://www.santacruz.com/news/supes_discuss_dangers_of_marijuana_farming.html Bob Fitzgerald

    What is pharmaceutical cannabis, and how does it compare to herbal cannabis?

    Pharmaceutical companies have developed drugs which either contain cannabinoids or have synthetic chemicals similar to those found in the cannabis plant. Some patients who want to use cannabinoids use pharmaceutical products only. Others use pharmaceutical products to complement their herbal cannabis use, or instead of cannabis, for example, when travelling. Other patients report that they prefer herbal cannabis.

    Two kinds of synthesized THC (dronabinol or Marinol® and nabilone or Cesamet®) have been approved for treatment of chemotherapy-related nausea and vomiting. Marinol® has also been approved for appetite and weight loss associated with HIV/AIDS wasting syndrome. A recent pharmaceutical cannabis product called Sativex® has been approved in Canada for pain associated with advanced cancer and neuropathic pain associated with multiple sclerosis.

    Pharmaceutical products with only some of the plant molecules do not have the same potential benefits as herbal cannabis. In herbal cannabis, different cannabinoids—as well as the terpenoids and flavanoids—act to balance the psychoactive effects of THC and have other have medical properties. Marinol® and Cesamet® are based on only one component of cannabis (THC, or a related synthetic molecule). Some studies show that this can increase the risk of panic attacks and dysphoria; many patients have reported such negative side effects. Sativex® contains molecules taken directly from the cannabis plant, including THC and CBD, and does not seem to have the same negative side effects as the other pharmaceutical products. Patient responses to this product vary. While some find it effective, others do not. This may be because it is the equivalent of one strain of cannabis that is not effective for everyone.

    With inhalation, herbal cannabis takes effect very quickly. Because Marinol® and Cesamet® are swallowed in pill form, their effects are slower to be felt and it is therefore harder for a patient to find the right dosage. It is also difficult for patients to swallow pills while experiencing nausea. Sativex® is delivered via a spray absorbed through the patient’s mouth, so its onset time is quicker.

    The costs of herbal cannabis are currently only covered by health insurance in very limited circumstances, but the costs of some of the pharmaceutical products are covered. At this stage in its approval process (it currently has a Notice of Compliance with Conditions) the cost of Sativex® is not covered by all provincial and territorial health insurance plans, making this option more expensive than other pharmaceutical and herbal cannabis products.

    http://watchyourbud.com/marijuana-cures-cancer.html

  • https://www.santacruz.com/news/2013/06/25/supes_discuss_dangers_of_marijuana_farming Bob Fitzgerald

    What is pharmaceutical cannabis, and how does it compare to herbal cannabis?

    Pharmaceutical companies have developed drugs which either contain cannabinoids or have synthetic chemicals similar to those found in the cannabis plant. Some patients who want to use cannabinoids use pharmaceutical products only. Others use pharmaceutical products to complement their herbal cannabis use, or instead of cannabis, for example, when travelling. Other patients report that they prefer herbal cannabis.

    Two kinds of synthesized THC (dronabinol or Marinol® and nabilone or Cesamet®) have been approved for treatment of chemotherapy-related nausea and vomiting. Marinol® has also been approved for appetite and weight loss associated with HIV/AIDS wasting syndrome. A recent pharmaceutical cannabis product called Sativex® has been approved in Canada for pain associated with advanced cancer and neuropathic pain associated with multiple sclerosis.

    Pharmaceutical products with only some of the plant molecules do not have the same potential benefits as herbal cannabis. In herbal cannabis, different cannabinoids—as well as the terpenoids and flavanoids—act to balance the psychoactive effects of THC and have other have medical properties. Marinol® and Cesamet® are based on only one component of cannabis (THC, or a related synthetic molecule). Some studies show that this can increase the risk of panic attacks and dysphoria; many patients have reported such negative side effects. Sativex® contains molecules taken directly from the cannabis plant, including THC and CBD, and does not seem to have the same negative side effects as the other pharmaceutical products. Patient responses to this product vary. While some find it effective, others do not. This may be because it is the equivalent of one strain of cannabis that is not effective for everyone.

    With inhalation, herbal cannabis takes effect very quickly. Because Marinol® and Cesamet® are swallowed in pill form, their effects are slower to be felt and it is therefore harder for a patient to find the right dosage. It is also difficult for patients to swallow pills while experiencing nausea. Sativex® is delivered via a spray absorbed through the patient’s mouth, so its onset time is quicker.

    The costs of herbal cannabis are currently only covered by health insurance in very limited circumstances, but the costs of some of the pharmaceutical products are covered. At this stage in its approval process (it currently has a Notice of Compliance with Conditions) the cost of Sativex® is not covered by all provincial and territorial health insurance plans, making this option more expensive than other pharmaceutical and herbal cannabis products.

    http://watchyourbud.com/marijuana-cures-cancer.html